Raymond James Financial Services Advisors, Inc. Revolution Medicines, Inc. Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 35,730 shares of RVMD stock, worth $2.02 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,730Holding current value
$2.02 Million% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding RVMD
# of Institutions
266Shares Held
161MCall Options Held
260KPut Options Held
620K-
Vanguard Group Inc Valley Forge, PA14.9MShares$842 Million0.01% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$757 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA11.4MShares$644 Million0.09% of portfolio
-
Farallon Capital Management LLC San Francisco, CA11.3MShares$639 Million2.58% of portfolio
-
Baker Bros. Advisors LP New York, NY7.57MShares$427 Million3.67% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $4.95B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...